FMED.US Fidelity Disruptive Medicine ETF

ETF Healthcare Equity Fidelity Investments USA Stocks
- USD
No recent price
Total assets
30.3M
Expense ratio
0.51%
Dividend yield
-
1-year return
+21.24%
Holdings
70
Since
2020

Fund data as reported by the issuer, updated Nov 13, 2026. Total assets are in the fund's base currency.

What does FMED.US invest in?

  • Mostly US stocks (95.8%)
  • Largest sector: Healthcare (100.0%)
  • Largest region: North America (98.8%)
  • Top 3 holdings: 12.0% of the fund

Asset allocation

  • US stocks 95.8%
  • Non-US stocks 6.5%
  • Cash 0.6%
  • Other 0.0%

Top holdings

All holdings, sectors and regions

Fidelity Disruptive Medicine ETF performance

Sharpe ratio 0.69
This year
+21.84%
1 year
+21.24%
3 years
+17.71%
5 years
+0.82%

Volatility 23.3% over 1 year and 17.9% over 3 years. Moderate, similar to a broad stock index.

Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers

FMED.US price

Prices on the chart can differ slightly from the closing prices StockSummer shows.

About Fidelity Disruptive Medicine ETF

The fund normally invests at least 80% of assets in securities of disruptive medicine companies. Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers. Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time. The fund is non-diversified.

Full fund profile